National Methadone Conference 2001 Sponsored by American Methadone Treatment Association

Attention: This
presentation contains pictures and takes time to download. 

Please be patient!

Opioid Treatment in the 21st Century: Implementing the Vision

St. Louis

October 7-10, 2001

St. Louis Arch

Five YEAR PLAN AVAILABLE IN POLICY MAKERS LUNCHEON SECTION

 

Advocacy Events and Patient Participation

NAMA at AMTA Conference 2001

Sunday, October 7th

Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers

  • Fred Christie, AFFIRM (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

(Sponsored by the Center for Substance Abuse Treatment)

The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA

The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.

Presented to Dr. Marc Shinderman and the Center for Addiction Problems

(Sponsored by the Center for Substance Abuse Treatment)

Welcome Reception 6 P.M.

Monday, October 8th

Opening Address 8 A.M.

Policy Makers Luncheon 11 A.M. to 1 P.M.

Chair Mark Parrino, American Methadone Treatment Association

The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and
organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.

(Sponsored by the American Methadone Treatment Association)

Poster Session 2 P.M. 

The
Hepatitis C POSTER SESSION IS AVAILABLE AS POWERPOINT PRESENTATION ONLY! 

DOWNLOAD HCV PowerPoint Presentation

Hepatitis C and the Methadone Patient              
Authors

  • Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
  • Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
  • John Finger, NAMA (Regional Director), TexNAMA (President)
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)

NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)

Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.

Tuesday, October 9th

Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse
Authors

  • Joe Neuberger, Delaware NAMA (President)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee

Award Banquet 8 P.M.

The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work.

Wednesday, October 10th

Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors

  • Moderator, Howard Lotsof, NAMA Acting Membership Director
  • Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
  • Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health

Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews

  • Joycelyn Woods, NAMA Board of Directors (President)
  • Howard Lotsof, NAMA Acting Membership Director
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)

Sponsored by State of Missouri, Department of Mental Health

Closing Address 12 P.M.

Smoozing Around The Conference

A quick photo album of the conference.

 

NAMA HOME PAGE

Similar Posts

  • Making Methadone Safe

    Admin 08/05/2022

    p3″ align=”center”>References American Association for the Treatment of Opiate Dependence. QTc Interval Screening – AATOD Policy and Guidance Statement (March 30, 2009). Available from AATOD, 225 Varick Street, New York, NY 10014. Black, L. DEA officials visit Waukegan clinic during probe of methadone death. Chicago Tribune (August 7, 2009). Omaha News Staff. Father Believes Son…

  • Methadone in the Maintenance Treatment of Narcotic Addicts

    Admin 04/03/2022

     Note On This Page   Admission Requirements  Homes  Take Home Exceptions  (a) The Food and Drug Administration and the Drug Enforcement Administration recognize that the investigational use of methadone requiring the prolonged maintenance of narcotic dependence as part of a total treatment effort has shown promise in the management and rehabilitation of selected narcotic addicts. It…

  • Office Based Opioid Treatment (OBOT)

    Admin 12/18/2022

    What Is Office Based Opioid Treatment or OBOT? OBOT is the treatment of opiate addiction with a medication in a physicians’ office and outside of the clinic system. Two medications are available methadone and buprenorphrine that was recently approved. Each medication has specific requirements and regulations before it can be dispensed. Using buprenorphine the physician…

  • Blind Dosing

    Admin 05/05/2023

    Methadone maintenance treatment has been the most effective treatment for addiction to heroin resulting the cessation of heroin use and criminal behavior. Prior to the development of methadone maintenance treatment over 28 years ago narcotic addiction was considered incurable and a behavioral disorder under the control of law enforcement. Drs. Dole and Nyswander brought the…